- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00928538
Nurse Family Partnership (NFP) Contraceptive Study (NFP2)
Effectiveness of Home Based Distribution of Hormonal Contraceptives for Women at Risk for Unintended Pregnancy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators intend to accomplish this goal by strengthening the family planning component of a well-known, effective, home-based intervention, the Nurse Family Partnership (NFP), by enhancing the nurses' access to contraceptive supplies. The investigators believe that proposed modification to the intervention, giving the nurses the ability to deliver hormonal contraception in the home, will enable the nurses to bring about greater change in the reproductive health behavior of women at-risk for unintended pregnancy. Ultimately, the investigators believe this will increase the impact the NFP has had on conception rates during the first two postpartum years.
Participants will be enrolled through the Nurse Family Partnership program in the Public Health Departments in Seattle/King County, Thurston County and Clark County, Washington. The NFP program provides home visits for women anticipating a first birth. Inclusion criteria for participation include English or Spanish speaking (or both), enrolled in the NFP program, pregnant and anticipating a first birth, and 32 weeks or less gestation. NFP nurses will obtain written consent for the study as well as consent for family planning services.
The study will be a randomized clinical trial. After consent and enrollment in the study, we will randomize participants to receive either the usual NFP intervention or the enhanced NFP intervention that includes contraceptive administration and distribution. The usual NFP intervention includes interventions focused on pregnancy planning and contraceptive advice, with the prescription and dispensing of contraceptives provided through the women's primary care settings. The primary difference between routine NFP care and the enhanced intervention is the administration and distribution of hormonal contraception in the home with one exception. Because it is part of the usual intervention, when requested, NFP nurses will provide emergency contraceptives for participants in both arms of the study. Each participant assigned to the enhanced intervention will receive the routine NFP family planning counseling beginning during pregnancy, including information on available contraceptives. The nurse will also counsel participants on when to begin using contraceptives post-partum. Following delivery, the nurse will take a history to determine whether there are any contraindications to oral contraceptives, the contraceptive patch, the contraceptive vaginal ring or the depomedroxyprogesterone shot. The nurse will follow study protocols, approved by the Clark County, Thurston County and Seattle/King County Public Health Departments, when taking the history, and if necessary, obtain a urine pregnancy test. The nurse will obtain written consent for family planning services before providing contraceptives. The written consent form is similar to consent forms used in clinic settings. The nurse will continue to provide family planning counseling, including counseling on sexually transmitted infection (STI) prevention and cervical cancer screening, and a supply of condoms. The nurse will also offer a choice of a three-month supply of combination oral contraceptives, progestin-only oral contraceptives, contraceptive patches, the contraceptive vaginal ring or a depomedroxyprogesterone injection at no cost to the participant. Depending on the contraceptive method chosen, the nurse will provide education, counseling, and obtain written request and consent forms for the specific method. All written materials will be available in English and Spanish. Monolingual Spanish-speaking patients will receive services from Spanish speaking NFP nurses. The nurses will follow guidelines and standing orders developed by Dr. Gipson, the Co-Investigator for the study, subject to approval by the county Health Officer, when providing oral contraceptives, contraceptive patches, or the contraceptive vaginal ring or when administering the depomedroxyprogesterone shot. For women currently breastfeeding, the nurse will recommend and provide progestin-only oral contraceptives or administer the depomedroxyprogesterone shot. During frequent home visits, the NFP nurse will continue to counsel the participants while providing additional three to twelve-month supplies of contraceptives or administering the depomedroxyprogesterone injections for up to two years after delivery. By phone or through subsequent visits, the nurse will address any adverse reactions or other participant concerns and will provide refills or an alternative hormonal method as necessary.
For both groups (usual NFP care and enhanced intervention), the Research Associates (RAs) will gather data related to gaps in contraceptive coverage and repeat pregnancy every three months beginning six months after delivery (except at 12 months and two years postpartum). In addition, RAs will conduct phone surveys following enrollment and again at 3 months, 12 months and 24 months post delivery. The surveys will address factors that influence the rate and timing of subsequent pregnancy, including pregnancy intendedness, utilization of reproductive health services, perceived barriers to contraceptive use, satisfaction with birth control methods, and self-efficacy related to contraceptive use.
Aim 1 is to determine whether fewer participants in the enhanced intervention group experience more than a one month gap in effective contraceptive use (defined as methods with which < 10% of women experience an accidental pregnancy during a year of typical use) compared to participants in the usual care group. The investigators will answer this by comparing the incidence of gaps that occur in the twenty-four months after delivery using survival analysis methods. Aim 2 is to examine whether fewer participants in the enhanced intervention group experience a second pregnancy compared to participants in the usual care group. The methodology for Aim 2 will be the same as for Aim 1, with analysis based on incidence of second pregnancy rather than gap in effective contraceptive use. Aim 3 will be to explore how pregnancy intendedness modifies the outcomes in Aim 1 and Aim 2, using the same methodology as aims 1 and 2.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Washington
-
Olympia, Washington, United States, 98506
- Thurston County Public Health
-
Seattle, Washington, United States
- Seattle - King County Public Health
-
Vancouver, Washington, United States, 98666
- Clark County Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- English or Spanish speaking (or both)
- Enrolled in the NFP (Nurse Family Partnership) program
- 32 weeks or less gestation.
Exclusion Criteria:
- Not enrolled in the NFP program
- More than 32 weeks gestation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual NFP Care
Usual NFP care includes pregnancy planning and contraceptive advice during nurse home visits, with the prescription and dispensing of contraceptives provided through the women's primary care settings.
|
|
Experimental: Enhanced NFP Care
Enhanced NFP intervention includes usual NFP care plus the intervention that includes contraceptive administration and distribution in the home
|
Usual NFP care plus the enhanced care that includes contraceptive administration and distribution during nurse home visits.
Participants will have a choice of combined hormonal contraception (oral, patches or vaginal rings)or progestin-only contraception (oral or depomedroxyprogesterone acetate injections.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
One month gaps in effective contraceptive use (defined as methods with which < 10% of women experience an accidental pregnancy during a year of typical use)
Time Frame: Every three months after delivery for two years
|
Every three months after delivery for two years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Unintended pregnancy
Time Frame: Every three months after delivery for two years
|
Every three months after delivery for two years
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Alan L Melnick, MD, MPH, Oregon Health and Science University
Publications and helpful links
General Publications
- Melnick AL, Rdesinski RE, Creach ED, Choi D, Harvey SM. The influence of nurse home visits, including provision of 3 months of contraceptives and contraceptive counseling, on perceived barriers to contraceptive use and contraceptive use self-efficacy. Womens Health Issues. 2008 Nov-Dec;18(6):471-81. doi: 10.1016/j.whi.2008.07.011. Epub 2008 Oct 15.
- Rdesinski RE, Melnick AL, Creach ED, Cozzens J, Carney PA. The costs of recruitment and retention of women from community-based programs into a randomized controlled contraceptive study. J Health Care Poor Underserved. 2008 May;19(2):639-51. doi: 10.1353/hpu.0.0016.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 832
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Hopital Antoine BeclereUnknown
Clinical Trials on Enhanced NFP Care
-
Portland State UniversityCompletedPregnancy | Parenting | Violence | Emotional AbuseUnited States
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI); Denver Health and Hospital...RecruitingBody Weight | Body Composition | Blood Pressure | Diet Habit | Physical Inactivity | Blood SugarUnited States
-
McMaster UniversityCenters for Disease Control and Prevention; Public Health Agency of Canada... and other collaboratorsCompleted
-
Texas Tech UniversityAlliance for Potato Research and EducationActive, not recruitingType 2 Diabetes | Blood PressureUnited States
-
Simon Fraser UniversityUniversity of British Columbia; McMaster University; University of Victoria; Public... and other collaboratorsCompleted
-
The Miriam HospitalNational Institute on Aging (NIA)Recruiting
-
Massachusetts General HospitalActive, not recruiting
-
Baylor College of MedicineM.D. Anderson Cancer Center; Harris County Hospital District; Texas A&M University and other collaboratorsCompleted
-
MDRCJohns Hopkins University; Columbia University; University of Georgia; Mathematica... and other collaboratorsActive, not recruitingPregnancy | Infant DevelopmentUnited States
-
Medical University of South CarolinaActive, not recruitingSmoking CessationUnited States